Litcius/Paper detail

Amantadine in the treatment of Parkinson's disease and other movement disorders

Olivier Rascol, Margherita Fabbri, Werner Poewe

2021The Lancet Neurology197 citationsDOI

Topics & Concepts

AmantadineMedicineAnticholinergicMovement disordersDiseaseAnticholinergic agentsClinical trialDopaminergicSerotonergicParkinsonismDrugMotor symptomsLevodopaPharmacologyRandomized controlled trialSymptomatic treatmentPhysical medicine and rehabilitationDonepezilTardive dyskinesiaMotor activityNeuropharmacologyParkinson's diseaseTetrabenazineNeurological disorderDegenerative diseaseIntensive care medicineRapid eye movement sleepGlutamatergicParkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsParkinson's Disease and Spinal Disorders